Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.
The report details the trend, potential and market size of Bispecific Antibody Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bispecific Antibody Therapeuticmarket, defines the market attractiveness level of Bispecific Antibody Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bispecific Antibody Therapeutic industry, describes the types of Bispecific Antibody Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bispecific Antibody Therapeutic market and the development prospects and opportunities of Bispecific Antibody Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bispecific Antibody Therapeutic market in Chapter 13.
By Player:
Creative-biolabs
PharmAbcine
Sorrento Therapeutics
Patheon
By Type:
Bearing An Fc Region
Lacking An Fc Region
By End-User:
Osteology
Pulmonary
Respiratory Diseases
Oncology
Gene Therapy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bispecific Antibody Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bispecific Antibody Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bispecific Antibody Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bispecific Antibody Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bispecific Antibody Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.2 United States Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.3 Europe Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.4 China Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.5 Japan Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.6 India Bispecific Antibody Therapeutic Consumption (2017-2022)
-
7.7 South Korea Bispecific Antibody Therapeutic Consumption (2017-2022)
8 Region and Country-wise Bispecific Antibody Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Bispecific Antibody Therapeutic Consumption Forecast (2022-2028)
9 Global Bispecific Antibody Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Bispecific Antibody Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bearing An Fc Region Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lacking An Fc Region Consumption and Growth Rate (2017-2022)
-
9.2 Global Bispecific Antibody Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Osteology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pulmonary Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Respiratory Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Gene Therapy Consumption and Growth Rate (2017-2022)
10 Global Bispecific Antibody Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bearing An Fc Region Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lacking An Fc Region Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Osteology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Respiratory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
11 Global Bispecific Antibody Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bispecific Antibody Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bispecific Antibody Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bispecific Antibody Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bispecific Antibody Therapeutic Market Competitive Analysis
-
14.1 Creative-biolabs
-
14.1.1 Creative-biolabs Company Details
-
14.1.2 Creative-biolabs Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Creative-biolabs Bispecific Antibody Therapeutic Product and Service
-
14.2 PharmAbcine
-
14.2.1 PharmAbcine Company Details
-
14.2.2 PharmAbcine Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PharmAbcine Bispecific Antibody Therapeutic Product and Service
-
14.3 Sorrento Therapeutics
-
14.3.1 Sorrento Therapeutics Company Details
-
14.3.2 Sorrento Therapeutics Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sorrento Therapeutics Bispecific Antibody Therapeutic Product and Service
-
14.4 Patheon
-
14.4.1 Patheon Company Details
-
14.4.2 Patheon Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Patheon Bispecific Antibody Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bispecific Antibody Therapeutic
-
Figure Bispecific Antibody Therapeutic Picture
-
Table Global Bispecific Antibody Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bispecific Antibody Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bispecific Antibody Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bispecific Antibody Therapeutic Consumption by Country (2017-2022)
-
Figure United States Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bispecific Antibody Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Bispecific Antibody Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bispecific Antibody Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bearing An Fc Region Consumption and Growth Rate (2017-2022)
-
Figure Global Lacking An Fc Region Consumption and Growth Rate (2017-2022)
-
Figure Global Osteology Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Consumption and Growth Rate (2017-2022)
-
Figure Global Respiratory Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Bearing An Fc Region Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lacking An Fc Region Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Respiratory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bispecific Antibody Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bispecific Antibody Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Creative-biolabs (Foundation Year, Company Profile and etc.)
-
Table Creative-biolabs Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Creative-biolabs Bispecific Antibody Therapeutic Product and Service
-
Table PharmAbcine (Foundation Year, Company Profile and etc.)
-
Table PharmAbcine Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmAbcine Bispecific Antibody Therapeutic Product and Service
-
Table Sorrento Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Bispecific Antibody Therapeutic Product and Service
-
Table Patheon (Foundation Year, Company Profile and etc.)
-
Table Patheon Bispecific Antibody Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Patheon Bispecific Antibody Therapeutic Product and Service
-
